Royal Bank Of Canada Charles River Laboratories International, Inc. Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 155,104 shares of CRL stock, worth $27.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

155,104

Previous 166,795 7.01%

Holding current value

$27.1 Million

Previous $32.9 Million 12.86%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$178.58 - $220.69 $2.09 Million - $2.58 Million	-11,691 Reduced 7.01%	155,104 $28.6 Million
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $1.66 Million - $2.17 Million	-8,854 Reduced 5.04%	166,795 $32.9 Million
Q2 2024 Nov 06, 2024	SELL	$206.39 - $268.73 $115,991 - $151,026	-562 Reduced 0.32%	175,649 $36.3 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $479,031 - $623,722	2,321 Added 1.33%	176,211 $36.4 Million
Q1 2024 Nov 05, 2024	SELL	$203.52 - $273.43 $586,748 - $788,298	-2,883 Reduced 1.64%	173,328 $47 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $1.98 Million - $2.66 Million	-9,714 Reduced 5.29%	173,890 $47.1 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $933,157 - $1.35 Million	-5,672 Reduced 3.0%	183,604 $43.4 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $188,995 - $211,516	972 Added 0.52%	189,276 $37.1 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $3.64 Million - $4.16 Million	19,796 Added 11.75%	188,304 $39.6 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $470,514 - $637,323	-2,452 Reduced 1.43%	168,508 $34 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $2.16 Million - $2.73 Million	-10,936 Reduced 6.01%	170,960 $37.2 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $107 Million - $146 Million	-584,417 Reduced 76.26%	181,896 $35.8 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $2.13 Million - $3.15 Million	-10,426 Reduced 1.34%	766,313 $164 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $13.1 Million - $18.5 Million	51,139 Added 7.05%	776,739 $221 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $2.21 Million - $2.83 Million	6,303 Added 0.88%	725,600 $273 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $4.86 Million - $5.97 Million	-13,037 Reduced 1.78%	719,297 $297 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $215 Million - $272 Million	732,334 New	732,334 $271 Million

Others Institutions Holding CRL

# of Institutions

710

Shares Held

53.9M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.9B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Charles River Laboratories International, Inc. Transaction History